Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris

ClinicalTrials.gov ID: NCT02566369

Public ClinicalTrials.gov record NCT02566369. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 1:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Assessment of the efficacy and safety of CD5789 (trifarotene) 50μg/g cream applied once daily for 12 weeks in subjects with acne vulgaris.

Study identification

NCT ID
NCT02566369
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Galderma R&D
Industry
Enrollment
1,208 participants

Conditions and interventions

Eligibility (public fields only)

Age range
9 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2015 (Actual)
Primary completion
Nov 14, 2017 (Actual)
Completion
Nov 14, 2017 (Actual)
Last update posted
Nov 12, 2019

2015 – 2017

United States locations

U.S. sites
86
U.S. states
30
U.S. cities
81
Facility City State ZIP Site status
Galderma Investigational Site (8258) Mobile Alabama 36608 —
Galderma Investigational Site (# 8530) Glendale Arizona 85308 —
Galderma Investigational Site (# 8511) Phoenix Arizona 85018 —
Galderma Investigational Site (# 8009) Hot Springs Arkansas 71913 —
Galderma Investigational Site (# 8355) Rogers Arkansas 72758 —
Galderma Investigational Site (# 8456) Beverly Hills California 90212 —
Galderma Investigational site (8578) Cerritos California 90703 —
Galderma Investigational Site (# 8526) Clovis California 93612 —
Galderma Investigational Site (8577) Encinitas California 92024 —
Galderma Investigational Site (# 8224) Fremont California 94538 —
Galderma Investigational Site (# 8509) Fullerton California 92835 —
Galderma Investigational Site (# 8507) Huntington Beach California 92647 —
Galderma Investigational Site (# 8425) Newport Beach California 92663 —
Galderma Investigational Site (# 8052) Oceanside California 92056 —
Galderma Investigational Site (# 8528) Santa Ana California 92701 —
Galderma Investigational Site (# 8160) Santa Monica California 91301 —
Galderma Investigational Site (# 8443) Temecula California 92592 —
Galderma Investigational Site (8572) Colorado Springs Colorado 80920 —
Galderma Investigational Site (# 8510) Englewood Colorado 80113 —
Galderma Investigational Site (# 8370) Boynton Beach Florida 33437 —
Galderma Investigational Site (# 8543) Fort Lauderdale Florida 33316 —
Galderma Investigational Site (8143) Miami Florida 33175 —
Galderma Investigational site (8259) Miramar Florida 33027 —
Galderma Investigational Site (# 8522) North Miami Beach Florida 33162 —
Galderma Investigational Site (# 8531) Orange Park Florida 32073 —
Galderma Investigational Site (8502) Orlando Florida 32814 —
Galderma Investigational Site (#8213) Ormond Beach Florida 32174 —
Galderma Investigational Site (# 8529) Sanford Florida 32771 —
Galderma Investigational Site (# 8455) St. Petersburg Florida 33708 —
Galderma Investigational Site (# 8523) Tampa Florida 33609 —
Galderma Investigational Site (# 8126) West Palm Beach Florida 33401 —
Galderma Investigational Site (#8189) Snellville Georgia 30078 —
Galderma Investigational Site (8582) Idaho Falls Idaho 83404 —
Galderma Investigational Site (# 8367) Arlington Heights Illinois 60005 —
Galderma Investigational Site (8191) Chicago Illinois 60611 —
Galderma Investigational site (8571) Darien Illinois 60561 —
Galderma Investigational Site (8575) Oakbrook Terrace Illinois 60180 —
Galderma Investigational Site (# 8366) Plainfield Indiana 46168 —
Galderma Investigational Site (# 8532) Overland Park Kansas 66215 —
Galderma Investigational Site (# 8069) Louisville Kentucky 40202 —
Galderma Investigational Site (8092) Louisville Kentucky 40217 —
Galderma Investigational Site (8545) Owensboro Kentucky 42301 —
Galderma Investigational Site (8457) Monroe Louisiana 71203 —
Galderma Investigational site (8580) New Orleans Louisiana 70130 —
Galderma Investigational Site (# 8012) Glenn Dale Maryland 20769 —
Galderma Investigational Site (# 8525) Rockville Maryland 20850 —
Galderma Investigational Site (# 8541) Quincy Massachusetts 02169 —
Galderma Investigational Site (#8512) Bay City Michigan 48706 —
Galderma Investigational Site (8574) Clarkston Michigan 48346 —
Galderma Investigational Site (#8033) Clinton Township Michigan 48038 —
Galderma Investigational Site (8129) Fort Gratiot Michigan 48059 —
Galderma Investigational Site (# 8226) Warren Michigan 48088 —
Galderma Investigational Site (# 8521) Saint Joseph Missouri 64506 —
Galderma Investigational Site (#8027) St Louis Missouri 63141 —
Galderma Investigational Site (# 8544) Lincoln Nebraska 68502 —
Galderma Investigational Site (# 8108) Las Vegas Nevada 89144 —
Galderma Investigational Site (#8420) Newington New Hampshire 03801 —
Galderma Investigational Site (# 8506) Hackensack New Jersey 07601 —
Galderma Investigational Site (#8500) Brooklyn New York 11203 —
Galderma Investigational Site (8524) East Setauket New York 11733 —
Galderma Investigational Site (8568) New York New York 10022 —
Galderma Investigational Site (8585) New York New York 10028 —
Galderma Investigational Site (8279) New York New York 10075 —
Galderma Investigational Site (8566) Charlotte North Carolina 28277 —
Galderma Investigational Site (#8514) Hickory North Carolina 28602 —
Galderma Investigational Site (# 8195) Beachwood Ohio 44122 —
Galderma Investigational Site (# 8016) Cincinnati Ohio 45255 —
Galderma Investigational site (8595) Dublin Ohio 43016 —
Galderma Investigational Site (8188) Hershey Pennsylvania 17033 —
Galderma Investigational site (8353) Yardley Pennsylvania 19067 —
Galderma Investigational Site (# 8369) Charleston South Carolina 29414 —
Galderma Investigational Site (# 8117) Knoxville Tennessee 37917 —
Galderma Investigational Site (# 8515) Nashville Tennessee 37203 —
Galderma Investigational Site (# 8542) Arlington Texas 76017 —
Galderma Investigational Site (#8513) Austin Texas 78705 —
Galderma Investigational site (8579) Beaumont Texas 77701 —
Galderma Investigational Site (# 8245) Dallas Texas 75231 —
Galderma Investigational Site (8183) Houston Texas 77030 —
Galderma Investigational site (8576) Katy Texas 77949 —
Galderma Investigational Site (8583) Murphy Texas 75094 —
Galderma Investigational Site (8567) San Antonio Texas 78213 —
Galderma Investigational site (8433) San Antonio Texas 78218 —
Galderma Investigational site (8329) San Antonio Texas 78229 —
Galderma Investigational site (8106) Layton Utah 84041 —
Galderma Investigational Site (# 8214) Salt Lake City Utah 84117 —
Galderma Investigational Site (# 8351) Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02566369, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 12, 2019 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02566369 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →